% Expired Patents = 64.7

EPO Patents = 5

Forward Citations = 12

Loading Chart...

5 inventors (with patents filed for the assignee):

Zadik Hazan (17 out of 18 patents)

Andre C B Lucassen (11 out of 12 patents)

Konstantin Adamsky (7 out of 7 patents)

4. Nurit Novak (4 out of 4 patents)

5. Shimon Amselem (3 out of 38 patents)

17 patents: Sort by Forward Citations

1. 11207333 - Compositions comprising triterpenoids and uses thereof for treating optic neuropathy (2021-12-28),

2. 11173164 - Compositions comprising triterpenoids (2021-11-16),

3. 11083736 - Compositions comprising triterpenoids (2021-08-10),

4. 11000562 - Use of isolated fractions of mastic gum for treating optic neuropathy (2021-05-11),

5. 10806763 - Compositions of polymeric myrcene (2020-10-20),

6. 10751347 - Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy (2020-08-25),

7. 10588911 - Compositions comprising triterpenoids (2020-03-17),

8. 10561670 - Compositions comprising acidic extracts of mastic gum (2020-02-18),

9. 10307449 - Compositions of polymeric myrcene (2019-06-04),

10. 10285996 - Compositions comprising triterpenoids (2019-05-14),

11. 10251923 - Therapeutic uses of mastic gum fractions (2019-04-09),

12. 10159680 - Compositions comprising acidic extracts of mastic gum (2018-12-25),

13. 9770456 - Compositions comprising acidic extracts of mastic gum (2017-09-26),

14. 9655938 - Compositions of polymeric myrcene (2017-05-23),

15. 9364509 - Therapeutic uses of mastic gum fractions (2016-06-14),

Company Overview

Regenera Pharma Ltd. is a biotechnology company based in Ness Ziona, Israel, specializing in the development of innovative therapies for various medical conditions. The organization focuses on harnessing advanced regenerative medicine techniques, particularly in the fields of tissue repair and cellular regeneration. By leveraging cutting-edge research and technology, Regenera Pharma aims to address unmet medical needs and improve patient outcomes through its pioneering approaches in therapeutic development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#6 in Ness Ziona

#374 in Israel

#35,948 in the World

Ness Ziona, Israel

Regenera Pharma Ltd.

Forward Citations = 12

5 inventors:

Zadik Hazan (17 out of 18 patents)

Andre C B Lucassen (11 out of 12 patents)

Konstantin Adamsky (7 out of 7 patents)

4. Nurit Novak (4 out of 4 patents)

5. Shimon Amselem (3 out of 38 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regenera Pharma Ltd.. Retrieved from https://idiyas.com/company/regenera-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]